previous compound ID: 1909 next compound
InChIKey: RAOCRURYZCVHMG-UHFFFAOYSA-N
SMILES: CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 92
"F Liang" "V Mutyam" "M Mazur" "MJ Suto" "DM Bedwell" "E Falk Libby" "B Liu" "M Du" "L Rasmussen" "M Mense" "X Xue" "JS Hong" "SM Rowe" "H Shang" "JR Bostwick" "EL White" "KM Keeling"
ReferenceID: 53
"GW Carlile" "J Goepp" "D Rotin" "JW Hanrahan" "SD Macknight" "DY Thomas" "E Matthes" "R Robert" "J Liao" "B Kus"

chemical graph of compound 1909





CID is 4622
synonyms found at PubChem are:
Oxibendazole, 20559-55-1, Oxibendazolo, Loditac, Filaribits Plus, Anthelcide EQ, Oxibendazolum, Oxibendazolum [INN-Latin], Oxibendazolo [INN-Spanish], UNII-022N12KJ0X, EINECS 243-877-7, SKF 30310, SK&F 30310, methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate, Methyl 5-propoxy-2-benzimidazolecarbamate, MLS000069646, Methyl 5-n-propoxy-2-benzimidazole carbamate, 022N12KJ0X, C12H15N3O3, N-(2-(5-Propoxybenzimidazolyl)) methyl carbamate, 5-Propoxy-2-benzimidazolecarbamic acid methyl ester, SK&F-30310, NCGC00018238-04, (5-Propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester, SMR000058208, 2-BENZIMIDAZOLECARBAMIC ACID, 5-PROPOXY-, METHYL ESTER, N-(Propoxy-5, benzimidazolyl)-2, carbamate de methyle [French], Carbamic acid, (5-propoxy-1H-benzimidazol-2-yl)-, methyl ester, 5-Propoxy-2-(methoxycarbonylamino)benzimidazole, DSSTox_CID_25625, DSSTox_RID_81010, DSSTox_GSID_45625, Methyl (5-propoxy-1H-benzimidazol-2-yl)carbamate, methyl N-(5-propoxy-1H-benzimidazol-2-yl)carbamate, W-107609, methyl (5-propoxy-1h-benzo[d]imidazol-2-yl)carbamate, oxybendazole, N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester, AJ119,(+), CAS-20559-55-1, Oxibendazole [USAN:BAN:INN], Oxibendazole [USAN:INN:BAN], Anthelcide EQ (TN), Oxibendazole, ~98%, Spectrum_001699, AC1L1IKV, methyl 5-n-propoxy-2-benzimidazolecarbamate, Spectrum2_001556, Spectrum3_001951, Spectrum4_000836, Spectrum5_001219, Oxibendazole (USAN/INN), D0B9GM, cid_4622, BSPBio_003551, KBioGR_001411, KBioSS_002179, Oxibendazole, GlaxoSmithKline, MLS006011733, DivK1c_000096, SCHEMBL168101, SPECTRUM1503373, SPBio_001432, CHEMBL1087630, DTXSID5045625, N-(Propoxy-5, benzimidazolyl)-2, carbamate de methyle, BDBM31048, CHEBI:92907, CTK8G2219, HMS500E18, KBio1_000096, KBio2_002179, KBio2_004747, KBio2_007315, KBio3_002864, KS-00000GJR, MolPort-002-817-066, MolPort-003-666-482, NINDS_000096, RAOCRURYZCVHMG-UHFFFAOYSA-N, HMS1922A22, HMS2090F21, HMS2094M09, HMS3713J18, Pharmakon1600-01503373, HY-B0299, ZINC4685859, Tox21_110844, CCG-39334, NSC758459, s1851, STL301145, AKOS015895323, Tox21_110844_1, AC-8714, AN-7054, CCG-220608, CS-2333, DB04910, MCULE-8346438764, NSC-758459, IDI1_000096, NCGC00018238-01, NCGC00018238-02, NCGC00018238-03, NCGC00018238-05, NCGC00018238-06, NCGC00018238-07, NCGC00018238-08, NCGC00018238-09, NCGC00023557-03, NCGC00023557-04, NCGC00023557-05, AS-12166, LS-50577, SC-73431, AB0011434, AB2000332, KB-254690, TL8001701, 5-propoxy-2-(carbomethoxyamino)benzimidazole, FT-0630464, O0499, D05293, methyl 5-propoxy-1H-benzimidazol-2-ylcarbamate, AB00052350-06, AB00052350_07, AB00052350_08, Oxibendazole, VETRANAL(TM), analytical standard, 559O551, A814696, AJ-119/34637010, SR-01000000182, SR-05000002065, I06-0683, SR-01000000182-2, SR-05000002065-1, BRD-K52075715-001-02-6, BRD-K52075715-001-03-4, BRD-K84514357-001-02-9, Methyl (6-propoxy-1H-benzo[d]imidazol-2-yl)carbamate, methyl N-(6-propoxy-1H-1,3-benzodiazol-2-yl)carbamate, Oxibendazole, European Pharmacopoeia (EP) Reference Standard, Carbamic acid, N-(6-propoxy-1H-benzimidazol-2-yl)-, methyl ester